10 June 2025 | 4:36PM EDT Insmed Inc. (INSM): Positive Ph2b TPIP PAH data surpass expectations INSM reported positive topline data from the Ph2b TPIP PAH trial with the study meeting all primary and secondary efficacy endpoints. Notably, TPIP treatment (measured 24 hours at trough, and thereby supportive of once daily dosing) resulted in 35% placebo-adjusted reduction from baseline in PVR (p<0.001) and 35.5m placebo-adjusted improvement in 6MWT (p=0.003), consistent with our bull case scenario and driving s ...

10 June 2025 | 4:02PM EDT Cameco Corp. (CCJ): A new(er) revenue driver as Westinghouse poised to benefit from new reactor builds; raise estimates, PT; reiterate Buy Late last week, the Czech Republic and South Korea reached an agreement on a 2-reactor, ~$19bn project after a court overturned a legal challenge that had blocked the deal from going through (link). As Westinghouse and Korea Electric Power Corporation (KEPCO) and Korea Hydro & Nuclear Power Co. (KHNP) have a mutually beneficial framework agreeme ...

Investment Rating - The report assigns a Neutral rating to Brown & Brown Inc. (BRO) since May 13, 2025, with a current price of $105.49 and a target price of $119.00, indicating an upside potential of 12.8% [8][34]. Core Insights - The acquisition of Accession Risk Management Group for approximately $9.825 billion is expected to enhance BRO's scale and accelerate its revenue growth towards an intermediate goal of $8 billion [2][20]. - The deal is projected to close in the third quarter of 2025 and is anticipated to generate synergies of around $150 million by 2028, which will improve BRO's diversification and reduce its exposure to property catastrophe risks [1][20]. - The acquisition is expected to be accretive to BRO's earnings per share (EPS) by approximately 8% to 13% in 2026, driven by additional earnings from Accession and cost synergies [21][22]. Summary by Sections Acquisition Details - BRO announced the acquisition of Accession for a total consideration of $9.825 billion, which translates to a multiple of approximately 15.7x on Accession's 2024 adjusted EBITDAC [1]. - The deal is expected to close in Q3 2025, with BRO having already cleared the necessary antitrust waiting period [1]. Strategic Rationale - The acquisition aligns with BRO's strategy to gain scale in the U.S. retail P&C brokerage and employee benefits sectors, enhancing its presence in the middle-market segment [2]. - Accession's business model and geographic focus are similar to BRO's, which is expected to facilitate integration and operational synergies [2][30]. Financial Projections - The report provides financial forecasts for BRO, including adjusted net income estimates of $1.1 billion for 2024, increasing to $1.475 billion by 2027, with corresponding EPS growth from $3.86 to $5.18 [3][14]. - The expected revenue growth for Accession in 2025 is projected at 9%, with a slowdown anticipated from 17% growth in 2024 due to market conditions [24][19]. Valuation Metrics - The implied EV/NTM Adj. EBITDAC multiple for the acquisition is estimated to be in the range of 13.1x to 14.9x, which is competitive compared to industry peers [18][26]. - BRO's financial ratios indicate a P/E ratio of 24.2 for 2024, decreasing to 20.4 by 2027, reflecting a positive outlook on earnings growth [3][9].

10 June 2025 | 2:22PM BRT Brazil Utilities Incorporating the new opex methodology and weaker power demand into our models We update our estimates for Brazilian utilities Copel, Equatorial, Energisa, and Cemig to take into account the long-awaited new power distribution opex methodology, which was approved by the regulator on May 20th. Among the changes introduced, we highlight i) the revised time-frame for reference opex, now to be updated annually; ii) the simplification of the benchmark model including hi ...

10 June 2025 | 3:34PM BRT Pulp & Paper Monthly Tracker — May 2025 This monthly report includes charts and tables with key global data points for the pulp and paper sector. We track information from different data providers for both up- and downstream products across the supply chain, including inventories, production, apparent consumption and prices. Key highlights of the month: Marcio Farid +55(11)3371-4580 | marcio.farid@gs.com Goldman Sachs do Brasil CTVM S.A. Henrique Marques +55(11)3371-0778 | henrique ...

10 June 2025 | 6:42PM BST Europe Business Services: Staffing: May '25: Datapoints continue to improve in Europe The m-o-m volumes were up 1.8% in May'25 vs. April'25. French temp work turnover also improved to c.-1% vs. c-5% in April '25. Dutch turnover data also received today (June 10th) for the 5th 4-week period of 2025 (April 21st to May 18th), improved significantly to c.+5% yoy vs. c.-2% in the 4th 4-week period (March 24th to April 20th). Number of hours worked improved to c.-1% yoy vs. c.-6% in the ...

11 June 2025 | 12:11AM HKT China Consumer Staples: May Check In and Consumer Corp. Day Wrap: A bumpy road with policy swings, channel shift amid deflation We hosted multiple staple companies at our Consumer & Leisure Corporate Day and performed channel checks in the past weeks. We are seeing a bumpy road of demand recovery and still largely slow 2Q-to-date run-rates across staples sub-sectors, esp. for spirits, beer, and dairy. Recent policy tightening in alcohol consumption by government officers and civil ...

10 June 2025 | 1:10PM CDT Americas Food: NielsenIQ data thru 5/31: Solid total food sales growth, with continued pressure across most of packaged food Total food sales increased +2.8%/+3.2% y/y for R4/12-wks (in-line with the long-term trend of +LSD), driven by pricing and partially offset by lower volumes. However, we observed sales declines across most of our packaged food coverage, with HSY as the exception, noting support from pricing. Additionally, all companies within our coverage lost share in their ...

10 June 2025 | 12:43PM EDT Americas Consumer Products NielsenIQ data thru 5/31 - US Cosmetics sales inflect positively in latest 2-wk period Our View - US cosmetics & nails sales in Nielsen (incl Amazon 1P) grew +0.6% in the latest 2-wks ended 5/31 (vs -0.2%/-1.6% for 4-/12-wks), reflecting -LSD pressure on volumes against +LSD pricing. By category, lip cosmetics outperformed other categories, growing +9.5% (vs +7.7%/+5.6% for 4-/12-wks) on strong volume growth of +9.8% (vs +8.4%/+5.2% for 4-/12-wks). Face ...

10 June 2025 | 10:02AM PDT Insulet Corp. (PODD): 46th Annual Global Healthcare Conference — Key Takeaways Presenters: Ana Maria Chadwick (EVP, CFO) Bottom Line: The company reiterated its core strategic priorities (driving increased penetration in Type 1s, ramping adoption in the Type 2 population, and expanding internationally) as well as achieving at least 100bps of annual operating margin expansion. PODD shares were underperforming the S&P 500 by ~250bps (at the time of this note), mainly as investors de ...